Li‐Xia Peng

1.6k total citations · 1 hit paper
38 papers, 1.0k citations indexed

About

Li‐Xia Peng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Li‐Xia Peng has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Li‐Xia Peng's work include Inflammasome and immune disorders (4 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (3 papers). Li‐Xia Peng is often cited by papers focused on Inflammasome and immune disorders (4 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (3 papers). Li‐Xia Peng collaborates with scholars based in China, United States and Switzerland. Li‐Xia Peng's co-authors include Fei Luan, Nan Zeng, Yan Yang, Xirui He, Xuanying Li, Xin Chen, Lianfeng Zhang, Jianfu Li, Wanli Liu and Chenguang Xu and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Li‐Xia Peng

37 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extraction, purification, structural characteristics and biological properties of the polysaccharides from Codonopsis pilosula: A review

2021 168 citations Fei Luan, Li‐Xia Peng et al. Carbohydrate Polymers profile →

Peers

Li‐Xia Peng

IMMUN

ONCOL

PHARM

Shuang Sun China

J. K. Kundu South Korea

Cheng Ma China

Nan‐Lin Wu Taiwan

Leonardo A. Moraes United Kingdom

Lei Xia China

Jianping Xu China

Hee‐Jung Choi South Korea

Na Young Ko South Korea

Yeon Ho Choi South Korea

Shuang Sun China

Li‐Xia Peng

549 ×1.6

287 ×0.9

IMMUN

123 ×0.9

168 ×1.3

ONCOL

79 ×0.8

PHARM

Citations per year, relative to Li‐Xia Peng Li‐Xia Peng (= 1×) peers Shuang Sun

Countries citing papers authored by Li‐Xia Peng

Since Specialization

Citations

This map shows the geographic impact of Li‐Xia Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Xia Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Xia Peng more than expected).

Fields of papers citing papers by Li‐Xia Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Xia Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Xia Peng. The network helps show where Li‐Xia Peng may publish in the future.

Co-authorship network of co-authors of Li‐Xia Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Xia Peng. A scholar is included among the top collaborators of Li‐Xia Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Xia Peng. Li‐Xia Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Xianglong, Bin Liao, Shujuan Liao, et al.. (2025). Next-generation sequencing-based population genetics unravels the evolutionary history of Rhodomyrtus tomentosa in China. BMC Plant Biology. 25(1). 338–338. 1 indexed citations

Luan, Fei, et al.. (2023). [Experimental study of cardioprotective effects of Cinnamomi Ramulus and Cinnamomi Cortex formula granules on myocardial ischemia/reperfusion injury in rats based on efficacy of "warming and coordinating heart Yang"].. PubMed. 48(3). 725–735. 1 indexed citations

Wang, Jing, Jiabin Lu, Guanming Lu, et al.. (2023). Loss of monoacylglycerol O-acyltransferase 2 can be compensated for by diacylglycerol O-acyltransferases 1 and 2 resulting in a negligible influence on mammary cancer development found in a mouse model and verified in human tissues. SHILAP Revista de lepidopterología. 4. 9–9. 1 indexed citations

Li, Huiting, Li‐Xia Peng, Yan Mei, et al.. (2023). TSPAN1 inhibits metastasis of nasopharyngeal carcinoma via suppressing NF-kB signaling. Cancer Gene Therapy. 31(3). 454–463. 1 indexed citations

Liu, Zhi‐Jie, Lisheng Zheng, Chang‐Zhi Li, et al.. (2023). Correlated with better prognosis, CSTA inhibits metastasis of nasopharyngeal carcinoma cells via suppressing AKT signaling through promoting METTL3 degradation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(5). 166696–166696. 6 indexed citations

Wang, Jing, et al.. (2023). SPI1-Mediated Upregulation of the CST1 Gene as an Independent Poor Prognostic Factor Accelerates Metastasis in Esophageal Squamous Cell Carcinoma (ESCC) by Interacting with MMP2. Frontiers in Bioscience-Landmark. 28(9). 212–212. 3 indexed citations

Meng, Dong‐Fang, Haibo Zhang, Guoying Liu, et al.. (2023). Association of Socioeconomic Disparities With Nasopharyngeal Carcinoma Survival in an Endemic Area, China. Cancer Control. 30. 2915606309–2915606309. 2 indexed citations

Mei, Yan, Dehuan Xie, Li‐Xia Peng, et al.. (2022). Novel long noncoding RNA LINC02820 augments TNF signaling pathway to remodel cytoskeleton and potentiate metastasis in esophageal squamous cell carcinoma. Cancer Gene Therapy. 30(2). 375–387. 7 indexed citations

Luan, Fei, Zhili Rao, Li‐Xia Peng, et al.. (2022). Cinnamic acid preserves against myocardial ischemia/reperfusion injury via suppression of NLRP3/Caspase-1/GSDMD signaling pathway. Phytomedicine. 100. 154047–154047. 45 indexed citations

10.

Luan, Fei, Li Chen, Li‐Xia Peng, et al.. (2022). Cardioprotective effect of cinnamaldehyde pretreatment on ischemia/ reperfusion injury via inhibiting NLRP3 inflammasome activation and gasdermin D mediated cardiomyocyte pyroptosis. Chemico-Biological Interactions. 368. 110245–110245. 26 indexed citations

11.

Luan, Fei, Li‐Xia Peng, Qi Liu, et al.. (2021). Extraction, purification, structural characteristics and biological properties of the polysaccharides from Codonopsis pilosula: A review. Carbohydrate Polymers. 261. 117863–117863. 168 indexed citations breakdown →

12.

Luan, Fei, Li‐Xia Peng, Junbo Zou, et al.. (2021). Traditional Uses, Phytochemical Constituents and Pharmacological Properties of Averrhoa carambola L.: A Review. Frontiers in Pharmacology. 12. 699899–699899. 34 indexed citations

13.

Peng, Li‐Xia, Zhili Rao, Ruocong Yang, et al.. (2021). Cardioprotective activity of ethyl acetate extract of Cinnamomi Ramulus against myocardial ischemia/reperfusion injury in rats via inhibiting NLRP3 inflammasome activation and pyroptosis. Phytomedicine. 93. 153798–153798. 39 indexed citations

14.

Rao, Zhili, Jiuseng Zeng, Xiangyü Li, et al.. (2021). JFNE-A isolated from Jing-Fang n-butanol extract attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress and the NF-κB signaling pathway via promotion of autophagy. Phytomedicine. 96. 153891–153891. 16 indexed citations

15.

Yang, Junping, Rui Sun, Yun Cao, et al.. (2020). PTPN3 Inhibits the Growth and Metastasis of Clear Cell Renal Cell Carcinoma via Inhibition of PI3K/AKT Signaling. Molecular Cancer Research. 18(6). 903–912. 19 indexed citations

16.

Meng, Dong‐Fang, Lingling Guo, Li‐Xia Peng, et al.. (2020). Antioxidants suppress radiation-induced apoptosis via inhibiting MAPK pathway in nasopharyngeal carcinoma cells. Biochemical and Biophysical Research Communications. 527(3). 770–777. 17 indexed citations

17.

Li, Dan, Bo Li, Li‐Xia Peng, Rong Liu, & Nan Zeng. (2020). Therapeutic Efficacy of Piperazine Ferulate Combined With Irbesartan in Diabetic Nephropathy: A Systematic Review and Meta-analysis. Clinical Therapeutics. 42(11). 2196–2212. 13 indexed citations

18.

Huang, Hongbing, Li Cao, Li‐Xia Peng, et al.. (2016). Extracellular serglycin upregulates the CD44 receptor in an autocrine manner to maintain self-renewal in nasopharyngeal carcinoma cells by reciprocally activating the MAPK/β-catenin axis. Cell Death and Disease. 7(11). e2456–e2456. 45 indexed citations

19.

Xu, Heping, Xuanying Li, Dan Liu, et al.. (2013). Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature. 496(7446). 523–527. 310 indexed citations

20.

Xiao, Qiang, Qin Li, Yanhong Wu, et al.. (2012). Therapeutic efficacy of Oral administration of propranolol in infantile with face or head hemangioma. Zhonghua xiaoerwaike zazhi. 33(9). 644–646. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact